Docetaxel, 5-fluorouracil and leucovorin (DFL): An outpatient first line palliative regimen for advanced/metastatic gastric cancer.

被引：0
|
作者：
Eniu, A [1 ]
Ciuleanu, TE [1 ]
Todor, N [1 ]
Ghilezan, N [1 ]
机构：
[1] Canc Inst Ion Chiricuta, Outpatient Clin, Cluj Napoca, Romania
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
283P
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [1] DOCETAXEL, CISPLATIN, 5-FLUOROURACIL AND LEUCOVORIN AS FIRST-LINE THERAPY IN ADVANCED GASTRIC CANCER (AGC)
    Trusilova, E.
    Besova, N.
    Gorbunova, V. A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 250 - 251
  • [2] Bolus infusion of cisplatin, 5-fluorouracil, and leucovorin as alternative first-line therapy for advanced gastric cancer.
    Coelho, Rafael Correa
    Abreu, Pedro Duarte
    Monteiro, Mariana Ribeiro
    Stramosk, Ana Paula
    Gil, Roberto Almeida
    Siqueira, Mariana
    Vilhena Pereira, Bruno dos Santos
    Duque, Cristiano Guedes
    Palladino, Alexandre de Mendonca
    Graudenz, Marcia Silveira
    Andrade, Carlos J. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Treatment of advanced gastric cancer with a modified regimen of etoposide/leucovorin/5-fluorouracil
    Chiou, TJ
    Kung, SP
    Hsieh, RK
    Fan, S
    Tzeng, CH
    Wei, CH
    Chen, PM
    [J]. CANCER INVESTIGATION, 1996, 14 (03) : 197 - 201
  • [4] Combination treatment of infusional 5-fluorouracil, low-dose leucovorin and docetaxel (FLT) for advanced gastric cancer.
    Chung, HC
    Jeung, HC
    Rha, SY
    Noh, SH
    Roh, JK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 343S - 343S
  • [5] A phase II study of irinotecan, oxaliplatin, 5-fluorouracil, leucovorin (FOLFOXIRI) as a first-line chemotherapy in metastatic gastric cancer.
    Lee, J.
    Kang, W.
    Lee, S.
    Kwon, J.
    Kim, H.
    Lee, H.
    Lim, H.
    Park, J.
    Park, Y.
    Park, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 197S - 197S
  • [6] Results of observational study of docetaxel, platinum compounds, 5-fluorouracil and leucovorin as first-line therapy in advanced gastric cancer (AGC).
    Trusilova, Elena
    Besova, Nataliya
    Gorbunova, Vera A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] 5-Fluorouracil/Leucovorin, Oxaliplatin and Irinotecan (FOLFOXIRI) as First-Line Treatment of Advanced Gastric Cancer
    Grande, C.
    Martinez, M.
    Villanueva, M. J.
    Huidobro, G.
    Casal, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S469 - S469
  • [8] Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer
    Jung, Joo Young
    Kwon, Jung Hye
    Kim, Jung Han
    Song, Hun Ho
    Kim, Inho
    Lee, Keun Seok
    Kim, Hyo Jung
    Zang, Dae Young
    Ahn, Jin Seok
    Lee, Jung-Ae
    Park, Young-Iee
    [J]. ONCOLOGY REPORTS, 2009, 21 (02) : 523 - 529
  • [9] Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: Results of a phase II study
    Constenla M.
    Garcia-Arroyo R.
    Lorenzo I.
    Carrete N.
    Campos B.
    Palacios P.
    [J]. Gastric Cancer, 2002, 5 (3) : 142 - 147
  • [10] Experience with methotrexate, 5-fluorouracil, and leucovorin (MFL): A first line effective, minimally toxic regimen for metastatic breast cancer
    Auerbach, M
    Elias, EG
    Orford, J
    [J]. CANCER INVESTIGATION, 2002, 20 (01) : 24 - 28
12345